SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
July 10, 2008
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F
X
Form 40-F
---
---
[Indicate by check mark if the registrant is submitting the Form 6-K
in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes
No X
---
---
[Indicate by check mark if the registrant
is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes
No X
---
---
[Indicate by check mark whether by furnishing
the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes
No X
---
---
If "Yes" is marked, indicate below the file
number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Smith
& Nephew Plc
(Registrant)
Date: July 10, 2008
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Smith & Nephew appoints Non-Executive Director
10 July 2008
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the appointment of an additional Non-Executive Director to the Board.
Joseph C. Papa, aged 52, and based in Michigan is Chairman of Perrigo Company. Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. Joe has considerable experience in sales and marketing and has held senior management positions with Cardinal Health, Watson Pharmaceuticals, G.D. Searle and Novartis.
Joe will join the Board on 1 August 2008.
He has no details to disclose under paragraph 9.6.13 (2) to 9.6.13 (6) of The Listing Rules.
John Buchanan, Chairman of Smith & Nephew, said today: "We are delighted that Joe has agreed to join the Board. He will bring additional international experience in the medical technology industry. We are looking forward to working with him."
Enquiries
Investors
Liz Hewitt Tel: +44 (0) 20 7401 7646
Smith & Nephew
Group Director Corporate Affairs
Media
Jon Coles Tel: +44 (0) 20 7404 5959
Brunswick - London
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were $3.4 billion.
About Perrigo Company
Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).